Lymphoma, Extranodal NK-T-Cell - 25 Studies Found
Recruiting |
: Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas :
: 2016-08-04 : |
Recruiting |
: VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT) : Extranodal NK-T-Cell Lymphoma : 2015-09-06 :
|
Terminated |
: Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma : Extranodal NK-T-CELL LYMPHOMA : 2016-06-09 :
|
Recruiting |
: Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients : Extranodal NK-T-Cell Lymphoma, Nasal Type : 2017-03-09 : Combination Product: L-Asparaginase or or Pegaspargase containing chemotherapy Patients receive at least |
Recruiting |
: MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma : Extranodal NK-T-Cell Lymphoma, Nasal Type : 2016-04-29 :
|
Recruiting |
: GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma : Extranodal NK-T-Cell Lymphoma, Nasal Type : 2016-04-05 :
|
Recruiting |
: PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma : Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type : 2014-03-11 :
|
Completed |
: Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma : Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type : 2010-09-08 : Radiation: CCRT+MIDLE chemotherapy Patients are planned to be treated with CCRT plus MIDLE chemotherapy |
Completed |
: Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma : Peripheral T/NK-cell Lymphoma : 2010-08-30 : Biological: KW-0761 Intravenously 8 times at 1-week intervals |
Recruiting |
: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas :
|